Harpago-boswellia
Food supplement declared in France, declaration No 2022-3-634, decision dated 15 March 2022
Harpago-boswellia (Laboratoire Lescuyer) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Laboratoire Lescuyer
- Food business operator placing the product on the market
- LABORATOIRE LESCUYER (SAS)
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Comprimé
- Daily dose
- 2 comprimés
- Directions for use
- 1 comprimé 2 fois par jour, à avaler avec de l’eau au cours des repas.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 232101, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Boswellia serrata Roxb. ex Colebr. | Gomme résine | Extrait sec hydroalcoolique | 100 mg |
| Harpagophytum procumbens | Racine | Extrait sec hydroalcoolique | 1 g |
Additives
E460, E341, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Réservé à l'adulte. Déconseillé aux femmes enceintes et qui allaitent.Déconseillé en cas d'ulcères (estomac ou duodénum) ou de calculs biliaires. Demander conseil à un médecin au préalable.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Harpago-Boswellia SAS Prophar, declared in 2017 : different composition: 1 ingredient(s) added, 3 missing
Brand : Laboratoire Lescuyer